Published: Fri, September 18, 2020

U.S. drug company releases protocol for Covid-19 vaccine trial

U.S. drug company releases protocol for Covid-19 vaccine trial

Such attacks had multiplied in other countries involved in efforts to develop a vaccine, prompting an exchange of information between their respective spy services, she said.

However, according to the charity, nations such as the United Kingdom have already secured supplies of vaccines equivalent to five doses per person - apparently at the expense of not-so-wealthy nations that can't afford to strike similar deals.

"I will be happy to give other countries in the world some of the vaccines that have been contractually agreed with us if it turns out that we have more than we need", said Spahn.

It is a platform that will support the research, development, and manufacturing of a wide range of Covid-19 vaccine candidates that aims to deliver two billion doses of safe and effective vaccines by the end of 2021, which should be enough to protect high-risk and vulnerable people, as well as frontline healthcare workers.

As part of its new push, the Commission is urging the 27 European Union member states' governments to back negotiations with a seventh vaccine maker, the two sources said, after it reached deals with AstraZeneca and Sanofi and announced advanced talks with Johnson & Johnson, Moderna, Pfizer and CureVac for their potential COVID-19 shots.

Trump repeated on Wednesday that the first vaccine would be approved by October, increasing concerns that the White House will place pressure on the approval body, the Food and Drug Administration (FDA). "Even in the extremely unlikely event that all five vaccines succeed, almost two thirds [61%] of the world's population will not have a vaccine until at least 2022", the report said. The chances of some of these experiments failing is more likely, which will further increase the number of people who may not have access to the vaccine.

According to Oxfam, out of supply deals inked for 5.3 billion doses, 51 percent-2.728 billion-were bought by wealthy nations including the United Kingdom, U.S., Australia, Hong Kong and Macau, Japan, Switzerland, and Israel, and well as the European Union. By contrast, according to Oxfam, Bangladesh has just one dose for every nine people.

Moderna's CEO Stephane Bancel said on Thursday his company would know whether their vaccine works by November.

The charity group called for a "people's vaccine", which would be free and distributed based on the needs of the people. That's why we are calling on them to share their knowledge free of patents and to get behind a quantum leap in production to keep everyone safe.

"We in the Aids movement have seen in the past how corporations use monopolies to artificially restrict supplies of life-saving medicines and inflate their prices", she said.

Nine potential coronavirus vaccines are now undertaking clinical trials of which, supply deals of five companies have been made public, the report added.

Like this: